🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to measure how well taking lebrikizumab alone ...
Status
Active Not Recruiting
Location
Total Skin & Beauty Dermatology Center, PC DBA Total Dermatology
Start Date
2025-06-16
Trial ID
NCT07006792
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Completed
Location
Investigate MD
Start Date
2019-10-29
Trial ID
NCT04178967
Treatments Being Tested
The main purpose of this study is to assess the efficacy of lebrikizumab ve...
Status
Completed
Location
First OC Dermatology Research Inc
Start Date
2025-04-21
Trial ID
NCT06921759
Treatments Being Tested
The main purpose of this study is to look at the amount of the study drug, ...
Status
Completed
Location
LabCorp CRU, Inc.
Start Date
2021-06-02
Trial ID
NCT04840901
Treatments Being Tested
The main purpose of this study is to determine the tolerability and side ef...
Status
Completed
Location
Peking University People's Hospital
Start Date
2024-03-28
Trial ID
NCT06243198
Treatments Being Tested
This is an open-label, single arm study of 52 weeks duration. The study wil...
Status
Completed
Location
Pinnacle Research Group
Start Date
2020-02-11
Trial ID
NCT04250350
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy and safety of le...
Status
Completed
Location
Yanagihara dermatology clinic
Start Date
2021-03-10
Trial ID
NCT04760314
Treatments Being Tested
The reason for this study is to assess the impact of lebrikizumab on vaccin...
Status
Completed
Location
Clinical Research Center of Alabama- Birmingham
Start Date
2020-11-17
Trial ID
NCT04626297
Treatments Being Tested
The main purpose of this study is to assess the long-term safety and effica...
Status
Enrolling By Invitation
Location
Clinical Research Center of Alabama
Start Date
2023-03-09
Trial ID
NCT05735483
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Completed
Location
Johnson Dermatology
Start Date
2019-09-24
Trial ID
NCT04146363
Treatments Being Tested